93 related articles for article (PubMed ID: 2156319)
1. The postoperative problems and management of the liver transplant recipient.
Van Thiel DH; Dindzans VJ; Gavaler JS; Tarter RE
Prog Liver Dis; 1990; 9():657-85. PubMed ID: 2156319
[No Abstract] [Full Text] [Related]
2. Liver transplantation.
Stock PG; Payne WD
Crit Care Clin; 1990 Oct; 6(4):911-26. PubMed ID: 2265386
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal complications of liver transplantation.
Caraceni P; Fagiuoli S; Wright HI; Nadir A; Van Thiel DH
Ital J Gastroenterol; 1995; 27(1):29-39. PubMed ID: 7795285
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative disorder masquerading as rejection in liver transplant recipients--an early aggressive tumor with atypical presentation.
Howard TK; Klintmalm GB; Stone MJ; Cofer JB; Husberg BS; Goldstein RM; Gonwa TA
Transplantation; 1992 May; 53(5):1145-7. PubMed ID: 1316652
[No Abstract] [Full Text] [Related]
5. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
6. Hypertension after liver transplantation.
Textor SC; Canzanello VJ; Taler SJ; Schwartz L; Augustine J
Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):20-8. PubMed ID: 9346597
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation in children.
Muiesan P; Vergani D; Mieli-Vergani G
J Hepatol; 2007 Feb; 46(2):340-8. PubMed ID: 17161491
[TBL] [Abstract][Full Text] [Related]
8. [Liver transplantation. Current status and indications].
Pichlmayr R; Müller R; Schmidt FW; Brunner G; Burdelski M
Internist (Berl); 1987 Jan; 28(1):1-7. PubMed ID: 3553054
[No Abstract] [Full Text] [Related]
9. Gastrointestinal tract post-transplant lymphoproliferative disorder after liver transplantation.
Xie QF; Chen P; Chen XH; Liu JM; Lerut J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2017 Oct; 16(5):556-558. PubMed ID: 28992890
[No Abstract] [Full Text] [Related]
10. [Follow-up of liver transplantation].
Vasseur B; Samuel D
Gastroenterol Clin Biol; 1999 Jun; 23(5 Pt 2):B66-75. PubMed ID: 10897776
[No Abstract] [Full Text] [Related]
11. Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.
Hézode C; Duvoux C; Germanidis G; Roudot-Thoraval F; Vincens AL; Gaulard P; Cherqui D; Pawlotsky JM; Dhumeaux D
Hepatology; 1999 Sep; 30(3):775-8. PubMed ID: 10462385
[TBL] [Abstract][Full Text] [Related]
12. Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome.
Ueno T; Barri YM; Netto GJ; Martin A; Onaca N; Sanchez EQ; Chinnakotla S; Randall HB; Dawson S; Levy MF; Goldstein RM; Klintmalm GB
Transplantation; 2006 Aug; 82(4):501-7. PubMed ID: 16926594
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma.
Jiménez-Rivera C; Avitzur Y; Fecteau AH; Jones N; Grant D; Ng VL
Pediatr Transplant; 2004 Jun; 8(3):243-8. PubMed ID: 15176961
[TBL] [Abstract][Full Text] [Related]
14. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation at the University of Chicago.
Millis JM; Alonso EM; Piper JB; Bruce DS; Newell KA; Woodle ES; Baker AL; Whitington PF; Thistlethwaite JR
Clin Transpl; 1995; ():187-97. PubMed ID: 8794265
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation at California Pacific Medical Center, San Francisco, California.
Esquivel CO; Martinez O; Krams S; Lim J; So SK; Concepcion W; Cox KL; Keeffe EB
Clin Transpl; 1994; ():163-71. PubMed ID: 7547535
[TBL] [Abstract][Full Text] [Related]
17. Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome.
Fernández MC; Bes D; De Dávila M; López S; Cambaceres C; Dip M; Imventarza O
Pediatr Transplant; 2009 May; 13(3):307-10. PubMed ID: 18346039
[TBL] [Abstract][Full Text] [Related]
18. Withdrawal of immunosuppression in liver transplantation: lessons learned from PTLD.
Mazariegos GV
Pediatr Transplant; 2004 Jun; 8(3):210-3. PubMed ID: 15176955
[No Abstract] [Full Text] [Related]
19. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
[TBL] [Abstract][Full Text] [Related]
20. Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation?
Aucejo F; Rofaiel G; Miller C
J Hepatol; 2006 Jan; 44(1):19-23. PubMed ID: 16298453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
